Literature DB >> 23108356

Mini-chaperones: potential immuno-stimulators in vaccine design.

Azam Bolhassani1, Sima Rafati.   

Abstract

The immunogenic properties of heat shock proteins (HSPs) have prompted investigations into their application as immuno-modulatory agents. HSPs have been used as potent adjuvants in immunotherapy of cancer and infectious diseases. Some studies showed that immune activities reside within N- or C-terminal fragments of HSPs. These small fragments are sufficient to link peptides, to bind and be taken up by the receptors CD91 and scavenger receptor type A on antigen presenting cells (APCs). Thus, these mini-chaperones can be used in immunotherapy of tumors and vaccine development. The data clearly demonstrated the potential of using HSP fragments as a possible adjuvant to augment CTL response against infectious diseases. Some HSP domains have been shown to inhibit endothelial cell growth, angiogenesis or tumor growth. In this review, we describe the immuno-stimulatory activities of various mini-chaperones in development of different vaccine strategies (DNA-based vaccine and protein/peptide-based vaccines).

Entities:  

Keywords:  cancer; heat shock protein; immuno-adjuvant; infectious disease; mini-chaperone; vaccine

Mesh:

Substances:

Year:  2012        PMID: 23108356      PMCID: PMC3667931          DOI: 10.4161/hv.22248

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  70 in total

Review 1.  Role of antiheat shock protein 60 autoantibodies in atherosclerosis.

Authors:  K Mandal; G Foteinos; M Jahangiri; Q Xu
Journal:  Lupus       Date:  2005       Impact factor: 2.911

2.  GP96 C-terminal improves Her2/neu DNA vaccine.

Authors:  Nafiseh Pakravan; Hoorieh Soleimanjahi; Zuhair Mohammad Hassan
Journal:  J Gene Med       Date:  2010-04       Impact factor: 4.565

3.  A CpG oligodeoxynucleotide potentiates the anti-tumor effect of HSP65-Her2 fusion protein against Her2 positive B16 melanoma in mice.

Authors:  Youyou Yan; Zhao Cao; Ming Yang; He Li; Hongfei Wei; Yao Fu; Dandan Song; Liying Wang; Yongli Yu
Journal:  Int Immunopharmacol       Date:  2012-01-02       Impact factor: 4.932

4.  Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83.

Authors:  A I Rico; S O Angel; C Alonso; J M Requena
Journal:  Mol Immunol       Date:  1999-12       Impact factor: 4.407

5.  Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.

Authors:  C Barrios; A R Lussow; J Van Embden; R Van der Zee; R Rappuoli; P Costantino; J A Louis; P H Lambert; G Del Giudice
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

6.  A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.

Authors:  Bo Liu; Dongxia Ye; Xinxin Song; Xinhua Zhao; Linan Yi; Jietao Song; Zhiyuan Zhang; Qingzheng Zhao
Journal:  Vaccine       Date:  2008-01-22       Impact factor: 3.641

Review 7.  Heat shock proteins and toll-like receptors.

Authors:  Alexzander Asea
Journal:  Handb Exp Pharmacol       Date:  2008

8.  Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients.

Authors:  Azam Bolhassani; Farnaz Zahedifard; Yasaman Taslimi; Mohammad Taghikhani; Bijan Nahavandian; Sima Rafati
Journal:  Indian J Med Res       Date:  2009-11       Impact factor: 2.375

Review 9.  Facets of heat shock protein 70 show immunotherapeutic potential.

Authors:  Stephen M Todryk; Michael J Gough; A Graham Pockley
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

10.  Heat shock protein 70 (HSP70) induces cytotoxicity of T-helper cells.

Authors:  Constança Figueiredo; Miriam Wittmann; Dong Wang; Ralf Dressel; Axel Seltsam; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Blood       Date:  2008-11-18       Impact factor: 22.113

View more
  5 in total

1.  A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine.

Authors:  Awadalkareem Adam; Qing Shi; Binbin Wang; Jing Zou; Junhua Mai; Samantha R Osman; Wenzhe Wu; Xuping Xie; Patricia V Aguilar; Xiaoyong Bao; Pei-Yong Shi; Haifa Shen; Tian Wang
Journal:  Transl Res       Date:  2022-06-08       Impact factor: 10.171

Review 2.  Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.

Authors:  Asfar S Azmi; Bin Bao; Fazlul H Sarkar
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 3.  Heat-shock proteins as dendritic cell-targeting vaccines--getting warmer.

Authors:  Shaun McNulty; Camilo A Colaco; Lucy E Blandford; Christopher R Bailey; Selene Baschieri; Stephen Todryk
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

4.  Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab.

Authors:  Aidong Wang; Ming Cui; Hong Qu; Jiabo Di; Zaozao Wang; Jiadi Xing; Fan Wu; Wei Wu; Xicheng Wang; Lin Shen; Beihai Jiang; Xiangqian Su
Journal:  Oncotarget       Date:  2016-11-15

5.  Human Molecular Chaperone Hsp60 and Its Apical Domain Suppress Amyloid Fibril Formation of α-Synuclein.

Authors:  Hanae Yamamoto; Naoya Fukui; Mayuka Adachi; Eiichi Saiki; Anna Yamasaki; Rio Matsumura; Daichi Kuroyanagi; Kunihiro Hongo; Tomohiro Mizobata; Yasushi Kawata
Journal:  Int J Mol Sci       Date:  2019-12-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.